No advantage for the overall group of breast cancer patients undergoing adjuvant therapy with zoledronic acid

dc.contributor.author	Souchon, Rainer
dc.date.accessioned	2017-06-13T12:49:54Z
dc.date.available	2017-06-13T12:49:54Z
dc.date.issued	2012
dc.identifier.issn	0179-7158
dc.identifier.uri	http://hdl.handle.net/10900/76606
dc.language.iso	de	de_DE
dc.publisher	Heidelberg : Springer	de_DE
dc.relation.uri	http://dx.doi.org/10.1007/s00066-012-0252-7	de_DE
dc.rights	info:eu-repo/semantics/closedAccess
dc.subject.ddc	610	de_DE
dc.title	No advantage for the overall group of breast cancer patients undergoing adjuvant therapy with zoledronic acid	de_DE
dc.title.alternative	Kein Vorteil für die Gesamtgruppe der Mammakarzinompatientinnen durch adjuvante Therapie mit Zoledronsäure	de_DE
dc.type	Article	de_DE
utue.publikation.seiten	1157-58	de_DE
utue.personen.roh	Souchon, Rainer
dcterms.isPartOf.ZSTitelID	Strahlentherapie und Onkologie	de_DE
dcterms.isPartOf.ZS-Issue	12	de_DE
dcterms.isPartOf.ZS-Volume	188	de_DE
utue.fakultaet	04 Medizinische Fakultät	de_DE

Files in this item

Files	Size	Format	View
There are no files associated with this item.